Squarepoint Ops LLC Alector, Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.69 - $8.08 $223,525 - $317,414	39,284 New	39,284 $236,000
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $76,601 - $103,660	13,072 New	13,072 $78,000
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $15,162 - $28,223	-1,982 Reduced 7.86%	23,249 $236,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $522,075 - $833,236	-40,098 Reduced 61.38%	25,231 $360,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $374,325 - $494,071	-19,345 Reduced 22.85%	65,329 $1.35 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $1.83 Million - $3.34 Million	84,674 New	84,674 $1.93 Million
Q2 2021 Aug 16, 2021	SELL	$15.5 - $22.48 $332,862 - $482,758	-21,475 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $820,933 - $1.23 Million	-55,319 Reduced 72.04%	21,475 $433,000
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $510,608 - $907,144	-54,320 Reduced 41.43%	76,794 $1.16 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $1.38 Million - $3.27 Million	131,114 New	131,114 $1.38 Million
Q1 2020 May 15, 2020	SELL	$16.25 - $35.28 $784,663 - $1.7 Million	-48,287 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $684,226 - $980,226	48,287 New	48,287 $832,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.